[go: up one dir, main page]

WO2005044845A3 - Protein binding miniature proteins - Google Patents

Protein binding miniature proteins Download PDF

Info

Publication number
WO2005044845A3
WO2005044845A3 PCT/US2004/037210 US2004037210W WO2005044845A3 WO 2005044845 A3 WO2005044845 A3 WO 2005044845A3 US 2004037210 W US2004037210 W US 2004037210W WO 2005044845 A3 WO2005044845 A3 WO 2005044845A3
Authority
WO
WIPO (PCT)
Prior art keywords
protein binding
miniature proteins
polypeptide
binding miniature
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2004/037210
Other languages
French (fr)
Other versions
WO2005044845A2 (en
Inventor
Alanna S Schepartz
Jason W K Chin
Reena Zutshi
Stacey E Rutledge
Martin Joanne D Kehlbeck
Neal J Zondlo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yale University
Original Assignee
Yale University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yale University filed Critical Yale University
Priority to CA002544764A priority Critical patent/CA2544764A1/en
Priority to GB0609747A priority patent/GB2422836A/en
Publication of WO2005044845A2 publication Critical patent/WO2005044845A2/en
Publication of WO2005044845A3 publication Critical patent/WO2005044845A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/02—Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The present invention provides a protein scaffold, such as an avian pancreatic polypeptide, that can be modified by substitution of two or more amino acid residues that are exposed on the alpha helix domain of the polypeptide when the polypeptide is in a tertiary form.
PCT/US2004/037210 2003-11-04 2004-11-04 Protein binding miniature proteins Ceased WO2005044845A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA002544764A CA2544764A1 (en) 2003-11-04 2004-11-04 Protein binding miniature proteins
GB0609747A GB2422836A (en) 2003-11-04 2004-11-04 Protein binding miniature proteins

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51749603P 2003-11-04 2003-11-04
US60/517,496 2003-11-04

Publications (2)

Publication Number Publication Date
WO2005044845A2 WO2005044845A2 (en) 2005-05-19
WO2005044845A3 true WO2005044845A3 (en) 2006-03-02

Family

ID=34572947

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/037210 Ceased WO2005044845A2 (en) 2003-11-04 2004-11-04 Protein binding miniature proteins

Country Status (3)

Country Link
CA (1) CA2544764A1 (en)
GB (1) GB2422836A (en)
WO (1) WO2005044845A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19932688B4 (en) 1999-07-13 2009-10-08 Scil Proteins Gmbh Design of beta-sheet proteins of gamma-II-crystalline antibody-like
DE10324447A1 (en) 2003-05-28 2004-12-30 Scil Proteins Gmbh Generation of artificial binding proteins based on ubiquitin
EP1925664A1 (en) * 2006-11-15 2008-05-28 Scil proteins GmbH Artificial binding proteins based on a modified alpha helical region of ubiquitin
CA2782093A1 (en) 2009-12-14 2011-06-23 Scil Proteins Gmbh Modified ubiquitin proteins having a specific binding activity for the extradomain b of fibronectin
US9492572B2 (en) 2011-06-15 2016-11-15 Scil Proteins Gmbh Dimeric binding proteins based on modified ubiquitins
EP3145523A4 (en) * 2014-05-21 2018-02-21 President and Fellows of Harvard College Ras inhibitory peptides and uses thereof
US10858405B2 (en) 2015-02-06 2020-12-08 Navigo Proteins Gmbh EGFR binding proteins
AU2016293063B2 (en) 2015-07-16 2018-11-08 Navigo Proteins Gmbh Novel immunoglobulin-binding proteins and their use in affinity purification
JP2018520675A (en) 2015-07-20 2018-08-02 ナフィゴ プロテインズ ゲゼルシャフト ミット ベシュレンクテル ハフツングＮａｖｉｇｏ Ｐｒｏｔｅｉｎｓ ＧｍｂＨ Novel binding protein based on diubiquitin mutant protein and production method thereof
WO2017191252A1 (en) 2016-05-04 2017-11-09 Navigo Proteins Gmbh Targeted compounds for the site-specific coupling of chemical moieties comprising a peptide linker
US11014967B2 (en) 2016-08-11 2021-05-25 Repligen Corporation Alkaline stable Fc-binding proteins for affinity chromatography
WO2019091918A1 (en) 2017-11-07 2019-05-16 Navigo Proteins Gmbh Fusion proteins with specificity for ed-b and long serum half-life for diagnosis or treatment of cancer

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001081375A2 (en) * 2000-04-24 2001-11-01 Yale University Dna & protein binding miniature proteins
WO2003053996A2 (en) * 2001-12-20 2003-07-03 Kimberly-Clark Worldwide, Inc. Modular peptide-based reagent

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001081375A2 (en) * 2000-04-24 2001-11-01 Yale University Dna & protein binding miniature proteins
US20030166240A1 (en) * 2000-04-24 2003-09-04 Yale University DNA & protein binding miniature proteins
WO2003053996A2 (en) * 2001-12-20 2003-07-03 Kimberly-Clark Worldwide, Inc. Modular peptide-based reagent

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
CHIN JASON W ET AL: "Methodology for optimizing functional miniature proteins based on avian pancreatic polypeptide using phage display", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, vol. 11, no. 12, 18 June 2001 (2001-06-18), pages 1501 - 1505, XP002196761, ISSN: 0960-894X *
CHIN JW AND SCHEPARTZ A: "Design and Evolution of a Miniature BCL-2 binding protein", ANGEWANDTE CHEMIE. INTERNATIONAL EDITION, WILEY VCH VERLAG, WEINHEIM, DE, vol. 40, no. 20, 2001, pages 3806 - 3809, XP008020924, ISSN: 1433-7851 *
CUNNINGHAM B C ET AL: "MINIMIZED PROTEINS", CURRENT OPINION IN STRUCTURAL BIOLOGY, CURRENT BIOLOGY LTD., LONDON, GB, vol. 7, no. 4, August 1997 (1997-08-01), pages 457 - 462, XP001026709, ISSN: 0959-440X *
RUTLEDGE S E ET AL: "DESIGN AND SELECTION OF PROTEIN-BINDING MINIATURE PROTEINS", AMERICAN CHEMICAL SOCIETY. ABSTRACTS OF PAPER. AT THE NATIONAL MEETING, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, US, vol. 224, no. 1/2, 18 August 2002 (2002-08-18), pages ABSTRNOMEDI - 197, XP008047429, ISSN: 0065-7727 *
RUTLEDGE S E ET AL: "Molecular recognition of protein surfaces: high affinity ligands for the CBP KIX domain", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, US, vol. 125, no. 47, 26 November 2003 (2003-11-26), pages 14336 - 14347, XP002331700, ISSN: 0002-7863 *
SCHEPARTZ A: "DESIGN AND DISCOVERY OF FUNCTIONAL MINIATURE PROTEINS", AMERICAN CHEMICAL SOCIETY. ABSTRACTS OF PAPER. AT THE NATIONAL MEETING, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, US, vol. 223, no. 1/2, 7 April 2002 (2002-04-07), pages ABSTRNOORGN - 136, XP008047433, ISSN: 0065-7727 *

Also Published As

Publication number Publication date
GB0609747D0 (en) 2006-06-28
WO2005044845A2 (en) 2005-05-19
GB2422836A (en) 2006-08-09
CA2544764A1 (en) 2005-05-19

Similar Documents

Publication Publication Date Title
ATE302845T1 (en) CUTINASE VARIANTS
WO2006017538A3 (en) Hk1-binding proteins
WO2001081375A3 (en) Dna & protein binding miniature proteins
WO2008066583A3 (en) Cell-free synthesis of proteins containing unnatural amino acids
ATE549028T1 (en) STABLE ANALOGUES OF GLP-1
WO2006033859A3 (en) Compositions and methods for protein production
WO2005044845A3 (en) Protein binding miniature proteins
WO2006066024A8 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
AU2002217010A1 (en) Peptides, the production and use thereof for binding immunoglobulins
WO2005059131A3 (en) Protein binding miniature proteins and uses thereof
WO2006000350A3 (en) Cosmetic compositions containing protein hydrolysates
EA200802128A1 (en) NEW NUTRITSEVTIKY COMPOSITIONS
WO2005095442A8 (en) Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins
EA200701528A1 (en) NEW NUTRITSEVTIKY COMPOSITIONS
WO2003031598A3 (en) Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
WO2008060634A3 (en) Human complement c3 derivatives with cobra venom factor-like function
WO2005023992A3 (en) Compositions and methods for inhibiting white spot syndrome virus (wssv) infection
ATA9042002A (en) COMPOSITIONS FOR THE MANUFACTURE OF AMINO CLASSIC PRODUCTS
WO2005060350A8 (en) Diastereomeric peptides useful as inhibitors of membrane protein assembly
WO2007104945A3 (en) Proteins, nucleic acids and medicaments
DK1904529T3 (en) Use of Stefin A as a Scaffold Protein
WO2007081419A3 (en) Compositions and methods related to anti-fgf agents
WO2006086607A3 (en) Novel proteins with enhanced functionality and methods of making novel proteins using circular permutation
ATE550345T1 (en) SFRP, SFRP-INTERACTING PEPTIDE MOTIVES AND METHODS OF USE
WO2003057708A3 (en) Fusion proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2544764

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 0609747.1

Country of ref document: GB

Ref document number: 0609747

Country of ref document: GB

122 Ep: pct application non-entry in european phase